You are here:

rifampicin, isoniazid, pyrazinamide, ethambutol hydrochloride (Voractiv)

Advice

in the absence of a submission from the holder of the marketing authorisation:

rifampicin, isoniazid, pyrazinamide, ethambutol hydrochloride (Voractiv®) is not recommended for use within NHS Scotland.

Indication under review: initial treatment of tuberculosis according to World Health Organisation (WHO) guidelines.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: rifampicin, isoniazid, pyrazinamide, ethambutol hydrochloride (Voractiv)
SMC Drug ID: 876/13
Manufacturer: Genus Pharmaceuticals
Indication: Initial treatment of tuberculosis according to World Health Organisation (WHO) guidelines.
BNF Category:
Sub Category: 5.1 Antibacterial drugs
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 13 May 2013

Back